Clinical Nutrition for Cancer Care Market Share, Size, Trends, Industry Analysis Report, By Type (Oral Nutrition, Parenteral Nutrition, and Enteral Feeding Formulas); By Cancer Type; By Age Group; By Sales Channel, By Region; Segment Forecast, 2024- 2032

Clinical Nutrition for Cancer Care Market Share, Size, Trends, Industry Analysis Report, By Type (Oral Nutrition, Parenteral Nutrition, and Enteral Feeding Formulas); By Cancer Type; By Age Group; By Sales Channel, By Region; Segment Forecast, 2024- 2032

The global clinical nutrition for cancer care market size is expected to reach USD 7.11 billion by 2032, according to a new study by Polaris Market Research. The report “Clinical Nutrition for Cancer Care Market Share, Size, Trends, Industry Analysis Report, By Type (Oral Nutrition, Parenteral Nutrition, and Enteral Feeding Formulas); By Cancer Type; By Age Group; By Sales Channel; By Region; Segment Forecast, 2024- 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The ability of nutritional support products to improve the immunity of cancer patients by providing the required amount of nutrients is primarily responsible for the market growth. Moreover, the implementation of strategic initiatives such as new product launches, merges, acquisitions, alliance, and partnerships contribute to the market growth. For instance, in January 2024, Danone Nutricia announced a new partnership with Resilience to develop nutritional support module for patients with cancer. Such strategic initiatives will make nutrition an integral part of oncology treatment in the coming years.

Sedentary lifestyle, lack of physical activity, and inheritance are some of main causes of cancer. Growing prevalence of cancer disease, increasing incidence of malnourishment among cancer patients, improving infrastructure of cancer care centers, and rising hospital admissions for the treatment of various types of cancer are some of the major factors responsible for the growth of clinical nutrition for cancer care market. For instance, according as per the fact & figures published by the World Health Organization (WHO), in 2022, an estimated 20 million new cancer cases were reported in 115 countries across the world.

Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below:

High demand for personalized treatment, rising need to assess nutritional status during cancer therapy, and the advent of effective nutritional supplements with better treatment outcomes are expected to contribute to the market during the forecast period. Moreover, the necessity to modify the immune system among the cancer patients receiving immune-oncology treatment will increase the demand for nutritional supplements for cancer. Furthermore, rising focus of manufacturers towards educating healthcare practitioners on cancer nutrition as a complementary treatment will boost the market growth in the upcoming years.

Clinical Nutrition for Cancer Care Market Report Highlights

- The oral nutrition segment dominated the market, owing to the benefits such as ease of consumption and convenience offered by oral supplements to cancer patients.

- The lung cancer segment is expected to expand at the significant CAGR, owing to the high prevalence of lung cancer in the developed countries.

- The adults segment dominated the global market in 2023, owing to increasing occurrence rate of malnourishment among adult cancer patients.

- The online segment is anticipated to register the highest CAGR, owing to the increasing preference to online distribution.

- North America held the largest market share, owing to the high prevalence of cancer patients and rising need for assessment of nutritional status before cancer therapy.

- The market players include Nestlé Health Science, Abbott Nutrition, Danone Nutricia, Bayer AG, and Baxter among others.

Polaris Market Research has segmented the clinical nutrition for cancer care market report based on and region:

Clinical Nutrition for Cancer Care, Type Outlook (Revenue - USD Billion, 2019 - 2032)

- Oral Nutrition

- Parenteral Nutrition

- Enteral Feeding Formulas

Clinical Nutrition for Cancer Care, Cancer Type Outlook (Revenue - USD Billion, 2019 - 2032)

- Head & Neck Cancer

- Stomach & Gastrointestinal Cancers

- Blood Cancer

- Breast Cancer

- Lung Cancer

- Others

Clinical Nutrition for Cancer Care, Age Group Outlook (Revenue - USD Billion, 2019 - 2032)

- Adult

- Pediatric

Clinical Nutrition for Cancer Care, Sales Channel Outlook (Revenue - USD Billion, 2019 - 2032)

- Offline

- Online

Clinical Nutrition for Cancer Care, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

- North America

- U.S.

- Canada

- Europe

- Germany

- UK

- France

- Italy

- Spain

- Russia

- Netherlands

- Rest of Europe

- Asia Pacific

- China

- India

- Japan

- South Korea

- Indonesia

- Malaysia

- Australia

- Rest of Asia Pacific

- Latin America

- Argentina

- Brazil

- Mexico

- Rest of Latin America

- Middle East & Africa

- UAE

- Saudi Arabia

- Israel

- South Africa

- Rest of Middle East & Africa